The extracellular matrix (ECM) plays a pivotal role in maintaining tissue architecture and cellular function. Beyond its structural support, the ECM is increasingly recognized as a dynamic participant in various biological processes, influencing cell signaling, migration, and differentiation. These properties make the ECM a valuable tool in diagnostic innovations, particularly for early disease detection and precision medicine. ECM-based biomarkers are emerging as critical indicators of pathological changes, as alterations in ECM composition and structure are often associated with diseases such as cancer, fibrosis, and cardiovascular disorders. By analyzing ECM proteins, glycoproteins, and proteoglycans, researchers can detect early-stage disease markers, leading to more timely interventions. Imaging techniques that target ECM components, such as collagen or elastin, are improving diagnostic accuracy. Innovations in imaging, including multiphoton microscopy and second-harmonic generation, allow for real-time visualization of ECM changes at the cellular level, offering non-invasive options for diagnosis. Microfluidic devices are also being developed to simulate ECM environments, enabling high-throughput screening of biological samples and the identification of disease-related ECM interactions. These platforms enhance the precision of diagnostic assays by mimicking tissue-specific ECM conditions, thus improving the relevance and accuracy of results. As research continues to unveil the complex role of ECM in various diseases, its integration into diagnostic technologies promises to revolutionize healthcare by enabling earlier detection, better prognosis, and personalized treatment strategies. This paradigm shifts in diagnostics, facilitated by ECM-based approaches, holds great potential for advancing precision medicine and improving patient outcomes across a wide range of pathologies.